UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000001580
Receipt No. R000001836
Scientific Title GENOMIC DISEASE OUTCOME CONSORTIUM
Date of disclosure of the study information 2008/12/16
Last modified on 2019/11/22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title GENOMIC DISEASE OUTCOME CONSORTIUM
Acronym G-DOC
Scientific Title GENOMIC DISEASE OUTCOME CONSORTIUM
Scientific Title:Acronym G-DOC
Region
Japan

Condition
Condition metabolic syndrome
hypertension
chronic kidney disease
dyslipidemia
diabetes mellitus
obesity
preeclampsia
hyperuricemia
Classification by specialty
Medicine in general Cardiology Endocrinology and Metabolism
Nephrology Geriatrics
Classification by malignancy Others
Genomic information YES

Objectives
Narrative objectives1 Evaluation of difference of othe nset age of hard end points (renal death, acute myocardial infarction, stroke, admission for congestive heart failure, death) based on genotypes
Basic objectives2 Others
Basic objectives -Others Cohort study based on genotypes
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes renal death
acute myocardial infarction
admission for congestive heart failure
stroke
lower limb amputation
death
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria hypertension
diabetes mellitus
dyslipidemia
metabolic syndrome
chronic renal disease
Key exclusion criteria scute phase disorder
severe organ failure
Target sample size 3500

Research contact person
Name of lead principal investigator
1st name Tadashi
Middle name
Last name Konoshita
Organization Fukui University School of Medicine
Division name Third Department of Internal Medicine
Zip code 910-1193
Address 23-3, Matsuokashimoaizuki, Eiheiji, Fukui, 910-1193, Japan
TEL 0776-61-8353
Email konosita@u-fukui.ac.jp

Public contact
Name of contact person
1st name Tadashi
Middle name
Last name Konoshita
Organization Fukui University School of Medicine
Division name Third Department of Internal Medicine
Zip code 910-1193
Address 23-3, Matsuokashimoaizuki, Eiheiji, Fukui, 910-1193, Japan
TEL 0776-61-8353
Homepage URL
Email konosita@u-fukui.ac.jp

Sponsor
Institute GENOMIC DISEASE OUTCOME CONSORTIUM (G-DOC) STUDY INVESTIGATORS
Institute
Department

Funding Source
Organization Fukui University School of Medicine
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Fukui University Hospital Medical Research Support Center
Address 23-3, Matsuokashimoaizuki, Eiheiji, Fukui, 910-1193, Japan
Tel 0776-61-8529
Email chiken@ml.u-fukui.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 福井大学医学部附属病院

Other administrative information
Date of disclosure of the study information
2008 Year 12 Month 16 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2001 Year 06 Month 01 Day
Date of IRB
2001 Year 06 Month 01 Day
Anticipated trial start date
2001 Year 06 Month 01 Day
Last follow-up date
2026 Year 03 Month 31 Day
Date of closure to data entry
2026 Year 03 Month 31 Day
Date trial data considered complete
2026 Year 03 Month 31 Day
Date analysis concluded
2027 Year 12 Month 31 Day

Other
Other related information Obsevational assessment of onset of renal death, myocardial infarction, admission for congestive heart failure, stroke and death

Management information
Registered date
2008 Year 12 Month 16 Day
Last modified on
2019 Year 11 Month 22 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001836

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.